Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the Peripheral Blood.
Introduction:
Under physiological ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Friday, December 14
Treatment with Natalizumab in Patients with Multiple Sclerosis
by
All About MS
on Fri 14 Dec 2007 04:00 AM CST
|
||